Authors


Judith A. Neugroschl, MD

Latest:

Antipsychotics for Behavioral Disturbance in Dementia? A Clinical Conundrum

Although the adverse-effect profile of older, conventional (typical) antipsychotics has discouraged many clinicians from using them, they remain widely used in elderly patients with dementia.


Judith G. Edersheim, JD, MD

Latest:

Off-Label Prescribing

Medications cannot be marketed in the United States without an FDA determination that they are safe and effective for their intended use. To obtain such certification, pharmaceutical companies submit their products to rigorous scrutiny (eg, in vitro studies, animal studies, human clinical trials) and present the subsequent data to the FDA, which determines whether the medication in question is safe and effective for a specific purpose.


Judith J. Prochaska, PhD, MPH

Latest:

E-Cigarettes, Vaping, and Other Electronic Nicotine Products: Harm Reduction Pathways or New Avenues for Addiction?

This article summarizes data on e-cigarettes, provides recommendations and resources to learn more, and emphasizes the evidence for treating tobacco (traditional cigarettes) addiction in people with mental illness.


Judith Pentz, MD

Latest:

The Use of Meditation in Children With Mental Health Issues

This review provides information to assist clinicians who are considering mindfulness meditation for their patients.


Judith Puckett, MD

Latest:

Accepting Patients as They Are: The Joys and Pains of Street Rounds

A recent experience on street rounds offered a moment that brought this psychiatrist back to one of the main reasons she chose psychiatry as a profession.


Judith S. Beck, PhD

Latest:

A Conversation About Black Mental Health and How CBT Can Be a Powerful Tool for Healing

Learn more about how cognitive behavior therapy can be used as a healing tool in marginalized communities.


Judson A. Brewer, MD, PhD

Latest:

Anxiety Treatment at Your Fingertips

Key questions to consider when evaluating a digital therapeutic for anxiety.


Judy A. Greene, MD

Latest:

Autism, Pregnancy, and SSRIs: When the Media Distorts the Facts

Setting the record straight on the burgeoning field of reproductive psychiatry.


Judy Greene, MD

Latest:

Contraception and Misconceptions

Psychiatrists who treat women and adolescent girls may find it necessary to discuss with their patients reproductive planning and the role of contraception in setting comprehensive treatment goals. Here's why.


Julia L. Austin, MS

Latest:

Enlisting Family Members to Address Treatment Refusal in Substance Abusers

Anyone who is close to someone who abuses alcohol or drugs knows all too well that substance abusers do not typically seek treatment until they have experienced years of substance-related problems. During the first year after onset of a diagnosable substance use disorder, only 1 of 5 alcohol-dependent persons and 1 of 4 drug-dependent persons receive treatment.


Julie Bowen

Latest:

Gene Mutation Can Raise Risk of Alcohol and Drug Abuse

An interplay between genetic and early environmental factors contributes to the development of substance abuse.


Julie Dumas, PhD

Latest:

The Role of Estrogen in the Development of Age-Related Cognitive Impairment and Dementia

During and after menopause, many women report impairments in cognitive functioning. Should hormones be prescribed in an effort to mitigate cognitive symptoms of menopause?


Julie Kissack, PharmD, BCPP, FCCP

Latest:

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations

A focus on QTc monitoring in patients receiving psychotropics, especially when multiple medications are prescribed.


Julie Loebach Wetherell, PhD

Latest:

Treating Late-Life Anxiety

Despite high prevalence and negative consequences of anxiety disorders in later life, this area has received little research attention. A relatively small number of outcome investigations on late-life anxiety have focused on the impact of pharmacological and psychotherapeutic treatments.


Julie M. Zito, PhD

Latest:

Antidepressant Use in Children With Cancer

In 2007, cancer was diagnosed in 10,400 children and adolescents under the age of 15 years.1 While cancer remains the second leading cause of death in children, increasing numbers of children with cancer are surviving into adulthood.2 Over the past 30 years, 5-year survival rates for children with cancer have significantly improved, from 59% in 1975 to 1977 to 80% in 1996 to 2004.3 Pediatric cancer, increasingly considered a chronic rather than an acute condition, is an intense emotional and physical experience for patients and their families.4


Julie Schulman, MD

Latest:

Depression and Cardiovascular Disease

Depression is a risk factor for cardiovascular disease and death in many ways, directly and indirectly. It is independently linked to smoking, diabetes, and obesity-all of which are risk factors for coronary heart disease (CHD).1 Depressed patients are more likely to be noncompliant with treatment recommendations, including diet, medications, and keeping appointments, and are more likely to delay presentation for treatment with an acute coronary event.2-4


Julie Sherman, PhD

Latest:

What Are Common Comorbidities in ADHD?

In this article, Julie Sherman, PhD and Jay Tarnow, MD briefly discuss the latest research findings on ADHD.


Julio Licinio, MD

Latest:

Frontiers in Psychiatric Research

These are exciting times for genetics research: Science magazine chose our new appreciation of human genetic diversity as the scientific breakthrough of the year 2007.1 The year brought a new genetic bonanza with the announcement of the 1000 Genome Project, a plan to capture human diversity by obtaining the entire genome sequence information of 1000 individuals.


Jurgen Bardutzky, MD

Latest:

Stroke: While Current Treatment Is Limited, New Options Are on the Horizon

Current therapy for acute ischemic stroke remains limited to intravenous recombinant tissue plasminogen activator (tPA) administered within 3 hours of symptom onset, but despite strong evidence supporting its effectiveness,1-5 only 2% to 4% of all stroke patients currently receive tPA.


Jurgen Unutzer, MD, MPH, MA

Latest:

On the Loss of a Dear Friend

Dr Wayne Katon (1950-2015) revolutionized care for patients around the world.


Justin C. Mcarthur, MBBS, MPH

Latest:

Diagnostic Utility of the Subjective Peripheral Neuropathy Screen in HIV-Infected Patients

HIV/AIDS, peripheral neuropathy, sensory neuropathies, subjective peripheral neuropathy screen


Justin J. Trevino, MD

Latest:

Use of a Nasal Naloxone-Containing Kit in the Transition From Regional Psychiatric Hospital to Community Care: A 1-Year Follow-up Study

Details here about a protocol for opioid abusers and the mentally ill that helped avoid deaths from drug overdose after psychiatric hospitalization.


Justin O. Schechter, MD

Latest:

A Dog Says "Thank You"

The human-animal relationship can provide insight into the patient’s ability to connect, to interact, and to show care and empathy. Plus, companion animals tend not to breach confidentiality.


Justine Wittenauer, MD

Latest:

Confidentiality and the Family: 5 Guidelines for Better Outcomes

Family involvement is often misunderstood as being a hindrance to individuation, when in fact family-oriented interventions can improve patient functioning, agency, and autonomy.


Juvaria Anjum, MBBS

Latest:

Flakka: A Deadly High

The abuse of this dangerous designer drug that can be purchased online is rapidly on the rise in the US.


Jyoti Sachdeva, MD

Latest:

Psychiatric Care of Peripartum Women

This article summarizes clinically relevant advances in the psychiatric care of women during and after pregnancy, including recent changes in how the FDA classifies pregnancy risk for medications, and best practices in perinatal psychopharmacology.


K. Elan Jung, MD

Latest:

Posttraumatic Spectrum Disorder: A Radical Revision

The introduction of posttraumatic stress disorder (PTSD) into psychiatric nosology has brought about a great deal of insight as well as controversy. Have complex clinical manifestations of PTSD created a need for further clarification of the disorder?


K.H. Blacker, MD

Latest:

Gone to the Dogs

Insurance restrictions sometimes make for strange bedfellows. My story begins with a phone call from a man about to lose his job. He said that he had been placed on probation and was about to be fired. He asked if he could see me. We met the following day.


Kamaldeep Bhui, MD

Latest:

The Role of Psychiatrists in Countering Violent Extremism

There is no predictive tool that is likely to have validity for rare outcomes such as terrorist attacks. More here.


Karen Abdool, MD, PhD

Latest:

Lasting Ties in Just 8 Days: Mental Health in a World Without Psychiatrists

During their time in Ayacucho, these visiting psychiatrists learned that American psychiatric training has wide-reaching cultural value.

© 2024 MJH Life Sciences

All rights reserved.